Download full-text PDF |
Source |
---|
Am J Trop Med Hyg
December 2024
Department of Dermatology, The Second Hospital of Jilin University, Changchun, People's Republic of China.
Mycetoma is a granulomatous disease of subcutaneous tissue that is caused by different species of aerobic filamentous bacteria (actinomycetoma) or fungi (eumycetoma). Mycetoma treatment depends on the causative pathogen, and it mainly consists of antimicrobial interventions or surgery. Aspergillus terreus is an etiologic agent of invasive aspergillosis and a rare cause of eumycetoma that is common in central and southern China.
View Article and Find Full Text PDFPLoS One
October 2024
Department of Basic Medical Sciences, College of Medicine, Dar Al Uloom University, Riyadh, KSA.
Background: Drug-related problems (DRPs) significantly threaten the safety of the elderly. In order to improve pharmacists' ability to minimize these events, novel educational interventions that consider the current challenges in clinical practice are crucial.
Objectives: The primary objective is to assess the impact of two unique educational interventions on pharmacists' ability to identify DRPs.
Infect Dis Poverty
July 2024
Infection Medicine, Edinburgh Medical School: Biomedical Sciences, College of Medicine and Veterinary Medicine, The University of Edinburgh, 1 George Square, Edinburgh, EH8 9TB, Scotland, UK.
Antimicrob Agents Chemother
May 2024
Institute of Organic Chemistry, University of Würzburg, Würzburg, Germany.
Mycetoma is a devastating neglected tropical infection of the subcutaneous tissues. It is caused by fungal and bacterial pathogens recognized as eumycetoma and actinomycetoma, respectively. Mycetoma treatment involves diagnosing the causative microorganism as a prerequisite to prescribing a proper medication.
View Article and Find Full Text PDFSaudi Pharm J
December 2023
Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Buraydah 52571, Saudi Arabia.
Background: Huntington's disease is an inherited progressive neurodegenerative disorder caused by an expansion of the polyglutamine tract leading to malformation and aggregation of the mutant huntingtin protein in the cell cytoplasm and nucleus of affected brain regions. The development of neuroprotective agents from plants has received considerable research attention.
Objective: Our study aims to investigate the neuroprotective effects of luteolin and the mechanisms that underline its potential mediated protection in the mutant htt neuroblastoma cells.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!